Real-life clinical practice results with vinflunine in patients with relapsed platinum-treated metastatic urothelial carcinoma: an Italian multicenter study (MOVIE-GOIRC 01–2014)

BACKGROUND: Vinflunine is the only chemotherapeutic agent shown to improve survival in platinum-refractory patients with metastatic transitional cell carcinoma of the urothelium (TCCU) in a phase III clinical trial, which led to product registration for this indication in Europe. The aim of this stu...

Descripción completa

Detalles Bibliográficos
Autores principales: Passalacqua, Rodolfo, Lazzarelli, Silvia, Donini, Maddalena, Montironi, Rodolfo, Tambaro, Rosa, De Giorgi, Ugo, Pignata, Sandro, Palumbo, Raffaella, Ceresoli, Giovanni Luca, Del Conte, Gianluca, Tonini, Giuseppe, Morelli, Franco, Nolè, Franco, Panni, Stefano, Rondini, Ermanno, Guida, Annalisa, Zucali, Paolo Andrea, Doni, Laura, Iezzi, Elisa, Caminiti, Caterina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5517798/
https://www.ncbi.nlm.nih.gov/pubmed/28724419
http://dx.doi.org/10.1186/s12885-017-3466-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5517798/
https://www.ncbi.nlm.nih.gov/pubmed/28724419
http://dx.doi.org/10.1186/s12885-017-3466-3

Ejemplares similares